BPOM Ensures No Cases of Blood Clotting Due to AstraZeneca Covid-19 Vaccine

BPOM Pastikan Tidak Ada Kasus Pembekuan Darah Akibat Vaksin Covid-19 AstraZeneca

"BPOM Ensures No Cases of Blood Clotting due to AstraZeneca Covid-19 Vaccine"

"Dream - The AstraZeneca-produced Covid-19 vaccine has been proven to have side effects of thrombosis with thrombocytopenia syndrome (TTS) or blood clotting. This immediately became a concern for both the public and the government."

The side effects of the Covid-19 vaccine are immediately studied by the Indonesian Food and Drug Monitoring Agency (BPOM RI), the Ministry of Health, and the National Commission on Immunization Adverse Events Following Immunization (Komnas PP KIPI). All three parties also provide the same statement in response to public concerns.

"Until April 2024, there have been no reports of security incidents, including cases of TTS, in Indonesia related to the AstraZeneca COVID-19 vaccine."

BPOM revealed on May 5, 2024, as reported by Liputan6.

The potential for TTS cases is very minimal.

The possibility of TTS cases or blood clotting due to the AstraZeneca Covid-19 vaccine is also very minimal. This is because TTS can only occur 4-42 days after vaccination. Meanwhile, the distribution of the Covid-19 vaccine has been stopped because various countries have entered an endemic phase against the virus.

In addition, the World Health Organization (WHO) also revealed that TTS cases are considered very rare, with a scale of less than 1 case in 10 thousand occurrences.

The Government Monitors the Administration of Covid-19 Vaccines

Certainly, the government does not stand idly by and ignore the public's response to Covid-19 vaccination during the pandemic. The administration of Covid-19 vaccines continues to be monitored through active surveillance of Adverse Events Following Immunization (AEFI) during the period of March 2021-July 2022 in 14 sentinel hospitals in 7 provinces in Indonesia.

"Through the extended monitoring, there have been no cases of blood clotting after the administration of Covid-19 vaccines in Indonesia. However, the AstraZeneca Covid-19 vaccine, which is the most widely used during the pandemic, has been administered in 73 million out of 453 million doses."

The current TTS case is not caused by the administration of the Covid-19 vaccine.

The following is the translation of the given Bahasa text to English while preserving any HTML tags: Other vaccine doses are obtained from various brands such as Sinovac, Sinopharm, Pfizer, Moderna, and others. Based on the statement, it can be concluded that the Covid-19 vaccine does not cause blood clotting side effects in Indonesia. Although there are TTS cases in Indonesia currently, it can be ensured that the cause is not the Covid-19 vaccine that has been administered for a long time.

"If there are currently cases of TTS found in Indonesia, it is not because of the COVID vaccine because it has already passed the time range of occurrence."

According to Prof. Hinky Hindra Irawan Satari, Chairman of Komnas KIPI a while ago.

lifestyle

Designer Reveals the Complexity of Creating the Luxurious Mahalini Kebaya Worn During the Mepamit Procession

The main attraction lies in the back of the kebaya, where a picture of a Balinese temple becomes the center of attention.